[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574841":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":32,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":7,"eligibilityCriteria":38,"healthyVolunteers":39,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":58},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Lucia Catani, PhD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+390512143837","lucia.catani@unibo.it",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Bologna","40138","Italy","IT",{"type":25,"coordinates":26},"Point",[27,28],11.33875,44.49381,{"lat":28,"lon":27},[31],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100574841",false,"NCT06764524","Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management","Inclusion criteria for patients:\n\n* WHO2022-defined diagnosis of Hairy Cell Leukemia.\n* age ≥18 years.\n* signed informed consent.\n\nInclusion criteria for Healthy Donors:\n\n* age ≥18 years.\n* Volunteers in general good health, free from any disease or serious illness.\n* Signed informed consent.\n\nExclusion criteria\n\n\\- None",true,"ALL","18 Years",{"count":43,"type":44},50,"ESTIMATED","OBSERVATIONAL","Check whether patients with Hairy Cell Leukemia (HCL) of different status (at diagnosis, in complete remission \\> 2 years or relapsed requiring therapy) have a 'signature' of altered immunity based on extracellular vesicles (EV)",[48],"Hairy Cell Leukemia (HCL)","2025-01-02",{"date":51,"type":52},"2025-01-08","ACTUAL",{"date":54,"type":52},"2024-12-05",{"date":56,"type":44},"2027-12-04",{"name":5,"class":6},1]